Dear new members of the Editorial Board of IJMPR,

It is a great pleasure for me to announce the new Editorial Board of IJMPR for 2021.

IJMPR feels honoured and happy to announce, that Daniel S. Pine (MD), who is Chief of the Section on Development and Affective Neuroscience in the National Institute of Mental Health (NIMH) Intramural Research Program, has agreed to follow Katja Beesdo‐Baum as the new Associate Editor of IJMPR for the period 2021‐2026. With his acceptance we welcome an outstanding scientist and a key leader in many fields from methodology to therapeutics. Since medical school, Dr. Pine has been engaged in research focusing on the epidemiology, biology, and treatment of paediatric mental illnesses. His expertise is reflected in more than 600 peer‐reviewed papers. His main areas of expertise include biological and pharmacological aspects of mood, anxiety, and behavioural disorders in children, as well as classification of psychopathology across the lifespan. Together with the Wiley team and Dr. Freya Thiel as Assistant, we look forward to making IJMPR the leading peer review journal in psychiatric methodology. Dr. Pine will be mainly responsible for submissions from the Americas and Australia, Dr. Wittchen for Europe, Africa and Asia.

We also sadly announce, that my friend and colleague Katja Beesdo‐Baum has decided to move on to new responsibilities and step down as Associate Editor after many years of highly competent, reliable and inspired work. On behalf of Wiley, I want to thank her for the many years of hard work and the incredible reliability in which she has managed countless critical submissions. This is undoubtedly a great loss to the Journal, only compensated by the fact that she will remain on the Editorial Board to continue providing her most valuable input.

We also welcome a number of outstanding scientists as new additional members on the Editorial Board who are committed to improve and sharpen the future profile of IJMPR in many ways.

The IJMPR profile will be strengthened particularly on statistical, methodological, and design issues by the expertise of Philipp Batterham (PhD), Australian National University, Acton, Australia; Stefan Goerigk (PhD), Ludwig‐Maximilians University, Munich, Germany; Femke Lamers (PhD), University of Amsterdam, The Netherlands; Shannon Lange (PhD), University of Toronto, Canada; Zeina Mnemneh (PhD), ISI University of Michigan, USA; and Oleguer Plana‐Ripoll (PhD) from the NCRR Aarhus, Denmark.

The key areas of expertise are for Jim van Os (PhD) from the UMC Maastricht, The Netherlands, clinical and epidemiological research on risk factors and vulnerabilities; for Reinout Wiers (PhD), University of Amsterdam, The Netherlands, psychology and risk factor research; and for Adi (Ardesheer) Talati’s (PhD), Columbia University, USA the fields of neurobiology, translational research and epidemiology. Jaana Suvisaari (PhD), Finnish Institute of Mental Health, Finland is specialist in psychotic disorders, aetiology, pathophysiology, detection and outcome research.

Katharina Kircanski (PhD), NIMH, USA is a Staff Scientist in the Section on Severe Mood Disorders at the National Institute of Mental Health (NIMH) Intramural Research Program (IRP) and Melissa A. Brotman (PhD) is the Assistant Clinical Investigator of the Neuroscience and Novel Therapeutics Unit (NNT) at the National Institute of Mental Health (NIMH) Intramural Research Program (IRP). Both specialize in multi‐method affective neuroscience techniques (e.g., fMRI, behavioural paradigms, ESM) and mechanisms of psychopathology to guide the development of novel targeted interventions.

We hope that these new members of the IJMPR Editorial Board will outline their profiles further in a dedicated mission paper in the near future.

Last but not least we would also like to express our gratitude to all departing and past members of the IJMPR Editorial Board who have so relentlessly supported and promoted the success of our Journal. We will miss the contributions, hard work and critical input to IJMPR that they provided over the past decade.

Yours sincerely,

Hans‐Ulrich Wittchen

尊敬的 IJMPR 编委会新成员，

我很高兴宣布 IJMPR 2021 年新的编辑委员会。

IJMPR 感到很荣幸和高兴地宣布，Daniel S. Pine (MD)是美国国家心理健康研究所 (NIMH) 校内研究项目发展和情感神经科学部门的负责人，已同意跟随 Katja Beesdo-Baum 担任 2021-2026 年 IJMPR 的新副主编。有了他的接受，我们欢迎一位杰出的科学家和从方法论到治疗学的许多领域的关键领导者。自医学院以来，Pine 博士一直从事流行病学、生物学和儿科精神疾病治疗方面的研究。他的专长体现在 600 多篇同行评审论文中。他的主要专业领域包括儿童情绪、焦虑和行为障碍的生物学和药理学方面，以及整个生命周期的精神病理学分类。与 Wiley 团队和Freya Thiel 博士一起作为助理，我们期待使 IJMPR 成为精神病学方法论领域的领先同行评审期刊。Pine 博士将主要负责美洲和澳大利亚的投稿，Wittchen 博士将主要负责欧洲、非洲和亚洲的投稿。

我们还遗憾地宣布，我的朋友兼同事 Katja Beesdo-Baum 在经过多年高度称职、可靠和鼓舞人心的工作后，决定承担新的职责并辞去副主编的职务。我代表 Wiley，感谢她多年来的辛勤工作以及她管理无数重要提交的令人难以置信的可靠性。这对《华尔街日报》来说无疑是一个巨大的损失，但她将继续留在编辑委员会继续提供她最有价值的意见，这才弥补了这一点。

我们也欢迎一些杰出的科学家成为编辑委员会的新成员，他们致力于以多种方式改善和提高 IJMPR 的未来形象。

IJMPR 简介将通过澳大利亚阿克顿澳大利亚国立大学Philipp Batterham (PhD)的专业知识，特别是在统计、方法论和设计问题上得到加强；Stefan Goerigk（博士），德国慕尼黑路德维希-马克西米利安大学；Femke Lamers（博士），荷兰阿姆斯特丹大学；Shannon Lange（博士），加拿大多伦多大学；Zeina Mnemneh（博士），美国密歇根大学 ISI；和来自丹麦奥胡斯 NCRR 的Oleguer Plana-Ripoll（博士）。

来自荷兰马斯特里赫特 UMC 的Jim van Os (PhD)的主要专业领域是风险因素和脆弱性的临床和流行病学研究；对于Reinout Wiers（博士），荷兰阿姆斯特丹大学心理学及危险因素研究; 以及Adi (Ardesheer) Talati's (PhD)，哥伦比亚大学，美国，神经生物学、转化研究和流行病学领域。Jaana Suvisaari (PhD)，芬兰心理健康研究所，芬兰是精神障碍、病因学、病理生理学、检测和结果研究方面的专家。

Katharina Kircanski (PhD) , NIMH, USA 是美国国家心理健康研究所 (NIMH) 校内研究计划 (IRP) 严重情绪障碍科的一名职员科学家，Melissa A. Brotman (PhD)是美国国家心理健康研究所 (NIMH) 校内研究计划 (IRP)的助理临床研究员美国国家心理健康研究所 (NIMH) 校内研究计划 (IRP) 的神经科学和新型治疗学组 (NNT)。两者都专注于多方法情感神经科学技术（例如，fMRI、行为范式、ESM）和心理病理学机制，以指导新型靶向干预措施的开发。

我们希望 IJMPR 编辑委员会的这些新成员将在不久的将来在专门的任务文件中进一步概述他们的简介。

最后但并非最不重要的一点，我们还要对 IJMPR 编辑委员会的所有离任和前任成员表示感谢，他们如此无情地支持和促进了我们期刊的成功。我们将怀念他们在过去十年中为 IJMPR 提供的贡献、辛勤工作和重要投入。

此致，

汉斯-乌尔里希·维琴